Inborn Error of Immunity clinical trials
28 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
- Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
- EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
- Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
- Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
- TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
- Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
- Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
- Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- Genetic Analysis of Immune Disorders
- Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies
- Studies of Disorders With Increased Susceptibility to Fungal Infections
- The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
- Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
- Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
- Metabolic Profiling of Immune Responses in Immune-mediated Diseases
- Novel Genetic Disorders of the Immune System
- Detection and Characterization of Infections and Infection Susceptibility
- Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
- Biologics And Clinical Immunology Cohort at Sinai
- The Mechanistic Biology of Primary Immunodeficiency Disorders
- NIAID Centralized Sequencing Protocol
- Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations
- Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases
- Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
- Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Inborn Error of Immunity” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.